Let’s have a heart to heart – Cardiovascular disease trials enrolling
Clinical trials now enrolling.
We are looking for volunteers living with high cholesterol, diabetes or other cardiovascular diseases. Learn more about our clinical trial opportunities and receive a health check & medical advice.
Despite advances in treatment, cardiovascular disease is the leading cause of death worldwide, resulting in over 17 million deaths annually. More than 7 million people in the UK are living with cardiovascular disease. Keeping your heart healthy is the most important thing to prevent heart problems.
Several factors can enhance your risk of heart disease, such as high cholesterol, diabetes, poor diet, inactivity, smoking, being overweight, alcohol, stress or a family history of cardiac disease. Elevated low-density lipoprotein associated cholesterol (LDL-C) is a major risk factor for the development of cardiovascular disease. Lowering LDL-C has been shown to reduce the risk of death or heart attack.
We need your help to advance world medicine and are investigating treatments to reduce cardiovascular events by lowering cholesterol levels.
If you or someone you know meets any of the following criteria:
- High cholesterol or hypertension
- Diabetes
- Angina
- Heart failure
- Peripheral arterial disease
- Having had a heart attack or stroke
- Having had bypass operations, operations on arteries or stents fitted
- Taking lipid lowering medication such as statins or are intolerant to them
- Family history of heart disease
We invite you to find out more about becoming a clinical trial volunteer today.
Help us fight heart disease. Together for the future of health.
As one of the largest and most recognised clinical study organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself. A clinical trial offers an opportunity to help researchers find better treatments for others in the future.
All Synexus clinical trials are approved by an independent ethics committee.